Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estrane-3,17-dione is a synthetic steroid belonging to the class of estrogens and derivatives. It is a C18 steroid with ketone groups at positions 3 and 17 on the estrane backbone. The compound exists in both (5alpha) and (5beta) stereoisomeric forms[1][8][9]. Estrane derivatives are structurally related to natural estrogens but lack significant estrogenic activity themselves; instead they serve as intermediates or metabolites in steroid biosynthesis pathways[1]. Estrane‑3,17‑dione has been studied primarily as an experimental compound and is known to act as a potent inhibitor of certain isomerase enzymes such as steroid delta-isomerase from Comamonas testosteroni[1]. There are no approved medical indications for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on estrane-3,17-dione.